ATE364604T1 - Alkyletherderivate oder deren salze - Google Patents
Alkyletherderivate oder deren salzeInfo
- Publication number
- ATE364604T1 ATE364604T1 AT02777882T AT02777882T ATE364604T1 AT E364604 T1 ATE364604 T1 AT E364604T1 AT 02777882 T AT02777882 T AT 02777882T AT 02777882 T AT02777882 T AT 02777882T AT E364604 T1 ATE364604 T1 AT E364604T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl ether
- ether derivatives
- salts
- new
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001321381 | 2001-10-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE364604T1 true ATE364604T1 (de) | 2007-07-15 |
Family
ID=19138603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02777882T ATE364604T1 (de) | 2001-10-19 | 2002-10-18 | Alkyletherderivate oder deren salze |
Country Status (23)
Country | Link |
---|---|
US (4) | USRE43676E1 (de) |
EP (1) | EP1437353B1 (de) |
JP (1) | JP4398247B2 (de) |
KR (1) | KR100956990B1 (de) |
CN (2) | CN100500662C (de) |
AT (1) | ATE364604T1 (de) |
AU (1) | AU2002344107B2 (de) |
BR (1) | BRPI0213393B8 (de) |
CA (1) | CA2464358C (de) |
CY (1) | CY1106714T1 (de) |
DE (1) | DE60220694T2 (de) |
DK (1) | DK1437353T3 (de) |
ES (1) | ES2287324T3 (de) |
HU (1) | HU230407B1 (de) |
IL (2) | IL161308A0 (de) |
MX (1) | MXPA04003541A (de) |
NO (1) | NO325780B1 (de) |
NZ (1) | NZ532328A (de) |
PL (2) | PL215264B1 (de) |
PT (1) | PT1437353E (de) |
RO (1) | RO122203B1 (de) |
WO (1) | WO2003035647A1 (de) |
ZA (1) | ZA200402806B (de) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0213393B8 (pt) | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
SI1514542T1 (sl) * | 2002-06-14 | 2012-06-29 | Toyama Chemical Co Ltd | Farmacevtska sestava, vsebujoäśa takrin ali donepezil za izboljĺ anje moĺ˝ganske funkcije |
ZA200508166B (en) | 2003-04-17 | 2007-03-28 | Toyama Chemical Co Ltd | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
AU2011204959B2 (en) * | 2005-03-28 | 2012-04-12 | Toyama Chemical Co., Ltd. | Process for production of 1-(3-(2-(1-benzothiophen-5-YL)- ethoxy)propyl)azetidin-3-ol or salts thereof |
EP1864978A4 (de) * | 2005-03-28 | 2009-07-01 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol oder salzen davon |
JP4902247B2 (ja) * | 2005-04-08 | 2012-03-21 | 富山化学工業株式会社 | 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体 |
JP2006328058A (ja) * | 2005-04-27 | 2006-12-07 | Toyama Chem Co Ltd | 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体 |
ZA200808728B (en) * | 2006-04-26 | 2010-01-27 | Toyama Chemical Co Ltd | Neurogenesis inducer or neuropathy Therapeutic agent comprising alkyl ether derivative or salt thereof |
US8119625B2 (en) * | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
ATE491705T1 (de) | 2006-08-04 | 2011-01-15 | Toyama Chemical Co Ltd | Verstärker der aktivität von proteinkinase c, enthaltend ein alkyletherderivat oder ein salz davon |
CN102046620B (zh) * | 2008-05-28 | 2014-04-09 | 富山化学工业株式会社 | 新的苯并噻吩氧化物衍生物及其盐 |
US9872914B2 (en) | 2012-02-22 | 2018-01-23 | Toyama Chemical Co., Ltd. | Solid pharmaceutical composition containing 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof |
WO2015115582A1 (ja) * | 2014-01-31 | 2015-08-06 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩を含有する神経損傷後のリハビリテーション効果促進剤 |
US10238632B2 (en) | 2015-06-11 | 2019-03-26 | Fujifilm Toyama Chemical Co., Ltd. | Sigma receptor-binding agent |
WO2017111005A1 (ja) | 2015-12-25 | 2017-06-29 | 富山化学工業株式会社 | 1-(3-(2-(1-ベンゾチオフェン-5-イル)エトキシ)プロピル)アゼチジン-3-オールまたはその塩を含む錠剤 |
CN110139641B (zh) * | 2016-12-28 | 2022-09-09 | 富士胶片富山化学株式会社 | 外用组合物 |
CN110167551B (zh) | 2016-12-28 | 2022-06-14 | 富士胶片富山化学株式会社 | 医药组合物 |
CN110121342A (zh) | 2016-12-28 | 2019-08-13 | 富士胶片富山化学株式会社 | 医药组合物 |
JP7079209B2 (ja) | 2016-12-28 | 2022-06-01 | 富士フイルム富山化学株式会社 | 医薬組成物およびその製造方法 |
BR112019024878A2 (pt) | 2017-06-02 | 2020-06-16 | Fujifilm Toyama Chemical Co., Ltd. | Agente para prevenção ou tratamento de tauopatia |
EP3636262A4 (de) | 2017-06-02 | 2020-06-10 | FUJIFILM Toyama Chemical Co., Ltd. | Mittel zur prävention und/oder behandlung von demenz vom alzheimertyp |
JP7282028B2 (ja) * | 2017-06-02 | 2023-05-26 | 富士フイルム富山化学株式会社 | 脳萎縮予防または治療剤 |
SG11201911519UA (en) * | 2017-06-02 | 2020-01-30 | Fujifilm Toyama Chemical Co Ltd | AGENT FOR REDUCING AMOUNT OF AMYLOID ß PROTEIN |
AU2018277981B2 (en) | 2017-06-02 | 2021-04-08 | Fujifilm Toyama Chemical Co., Ltd. | Agent for preventing or treating spinocerebellar ataxia |
JP7227914B2 (ja) | 2017-10-30 | 2023-02-22 | 富士フイルム富山化学株式会社 | エモパミル結合タンパク質結合剤およびその利用 |
CN114853619B (zh) * | 2022-05-19 | 2024-05-10 | 神隆医药(常熟)有限公司 | 一种适于工业化生产的n-甲基酪胺盐酸盐的制备方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH01156973A (ja) | 1987-09-04 | 1989-06-20 | Tanabe Seiyaku Co Ltd | ベンゾフラン誘導体 |
JP2887492B2 (ja) | 1990-02-05 | 1999-04-26 | 富山化学工業株式会社 | 1,2―エタンジオール誘導体およびその塩 |
JP3044055B2 (ja) | 1990-08-09 | 2000-05-22 | 富山化学工業株式会社 | 1,2―エタンジオール誘導体およびその塩 |
DK74693D0 (da) | 1993-06-23 | 1993-06-23 | Novo Nordisk As | Novel heterocyclic chemistry |
JP3232830B2 (ja) | 1993-11-30 | 2001-11-26 | 三菱電機株式会社 | フレキシブルディスク装置のキャリッジ機構 |
EP1020427B1 (de) * | 1994-10-25 | 2003-10-01 | Toyama Chemical Co., Ltd. | Ein Wirkstoff für die Forderung von Nervwachstumfaktor Aktivität, der ein 1,2-Ethandiol-Derivat oder ein Salz davon enthält |
JPH08268883A (ja) | 1994-10-25 | 1996-10-15 | Toyama Chem Co Ltd | 1−フェニル−1,2−エタンジオール誘導体またはそ の塩を含有する神経成長因子の作用増強剤 |
UA59341C2 (uk) | 1995-08-11 | 2003-09-15 | Пфайзер, Інк. | (1s,2s)-1-(4-гідроксифеніл)-2-(4-гідрокси-4-фенілпіперидин-1-іл)-1-пропанолметансульфонат тригідрат |
EP0873990A1 (de) | 1995-09-22 | 1998-10-28 | Yoshitomi Pharmaceutical Industries, Ltd. | Benzoesäureverbindungen und ihre medizinische anwendung |
DE19605610A1 (de) | 1996-02-15 | 1997-08-21 | Hoechst Ag | Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
WO1997030703A1 (fr) | 1996-02-20 | 1997-08-28 | Toyama Chemical Co., Ltd. | Agent ameliorant les fonctions cerebrales contenant des derives de 1,2-ethanediol ou des sels de celui-ci |
JP4549452B2 (ja) | 1997-12-12 | 2010-09-22 | 富山化学工業株式会社 | アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤 |
AU1506499A (en) * | 1997-12-12 | 1999-07-05 | Toyama Chemical Co. Ltd. | Alkyl ether derivatives or salts thereof and calcium antagonists containing the same |
DK1186594T3 (da) | 1999-06-11 | 2009-09-14 | Toyama Chemical Co Ltd | N-alkoxylkyl-N,N-dialkylamin-derivater eller salte deraf og midler mod neurodegenerative sygdomme, som indeholder disse |
BRPI0213393B8 (pt) | 2001-10-19 | 2021-05-25 | Fujifilm Toyama Chemical Co Ltd | derivados de éter alquílico, ou um de seus sais, processo para produzir um derivado de éter alquílico, derivado de alquil-amida, ou um de seus sais, e, composição farmacêutica |
SI1514542T1 (sl) | 2002-06-14 | 2012-06-29 | Toyama Chemical Co Ltd | Farmacevtska sestava, vsebujoäśa takrin ali donepezil za izboljĺ anje moĺ˝ganske funkcije |
ZA200508166B (en) | 2003-04-17 | 2007-03-28 | Toyama Chemical Co Ltd | Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
EP1864978A4 (de) | 2005-03-28 | 2009-07-01 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol oder salzen davon |
ZA200808728B (en) | 2006-04-26 | 2010-01-27 | Toyama Chemical Co Ltd | Neurogenesis inducer or neuropathy Therapeutic agent comprising alkyl ether derivative or salt thereof |
US8119625B2 (en) | 2006-04-26 | 2012-02-21 | Toyama Chemical Co., Ltd. | Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
ATE491705T1 (de) | 2006-08-04 | 2011-01-15 | Toyama Chemical Co Ltd | Verstärker der aktivität von proteinkinase c, enthaltend ein alkyletherderivat oder ein salz davon |
CN102046620B (zh) | 2008-05-28 | 2014-04-09 | 富山化学工业株式会社 | 新的苯并噻吩氧化物衍生物及其盐 |
-
2002
- 2002-10-18 BR BRPI0213393A patent/BRPI0213393B8/pt not_active IP Right Cessation
- 2002-10-18 PL PL369601A patent/PL215264B1/pl unknown
- 2002-10-18 AU AU2002344107A patent/AU2002344107B2/en not_active Expired
- 2002-10-18 DK DK02777882T patent/DK1437353T3/da active
- 2002-10-18 KR KR1020047005687A patent/KR100956990B1/ko active IP Right Grant
- 2002-10-18 RO ROA200400354A patent/RO122203B1/ro unknown
- 2002-10-18 CN CNB028206452A patent/CN100500662C/zh not_active Expired - Lifetime
- 2002-10-18 NZ NZ532328A patent/NZ532328A/en not_active IP Right Cessation
- 2002-10-18 DE DE60220694T patent/DE60220694T2/de not_active Expired - Lifetime
- 2002-10-18 CA CA2464358A patent/CA2464358C/en not_active Expired - Lifetime
- 2002-10-18 MX MXPA04003541A patent/MXPA04003541A/es active IP Right Grant
- 2002-10-18 WO PCT/JP2002/010827 patent/WO2003035647A1/ja active IP Right Grant
- 2002-10-18 JP JP2003538163A patent/JP4398247B2/ja not_active Expired - Lifetime
- 2002-10-18 US US13/327,152 patent/USRE43676E1/en not_active Expired - Lifetime
- 2002-10-18 US US10/492,774 patent/US7087594B2/en not_active Ceased
- 2002-10-18 PL PL402986A patent/PL217872B1/pl unknown
- 2002-10-18 CN CN2009102038534A patent/CN101643470B/zh not_active Expired - Lifetime
- 2002-10-18 ES ES02777882T patent/ES2287324T3/es not_active Expired - Lifetime
- 2002-10-18 IL IL16130802A patent/IL161308A0/xx unknown
- 2002-10-18 AT AT02777882T patent/ATE364604T1/de active
- 2002-10-18 EP EP02777882A patent/EP1437353B1/de not_active Expired - Lifetime
- 2002-10-18 PT PT02777882T patent/PT1437353E/pt unknown
- 2002-10-18 HU HU0500017A patent/HU230407B1/hu unknown
-
2004
- 2004-04-07 IL IL161308A patent/IL161308A/en active IP Right Grant
- 2004-04-13 ZA ZA2004/02806A patent/ZA200402806B/en unknown
- 2004-04-15 NO NO20041531A patent/NO325780B1/no not_active IP Right Cessation
-
2006
- 2006-05-03 US US11/416,321 patent/US7468443B2/en not_active Expired - Lifetime
-
2007
- 2007-07-09 CY CY20071100909T patent/CY1106714T1/el unknown
-
2008
- 2008-10-17 US US12/253,379 patent/US8129535B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE364604T1 (de) | Alkyletherderivate oder deren salze | |
DK0661269T3 (da) | Substituerede heterocykliske carboxylsyreamider, deres fremstilling og anvendelse som lægemidler. | |
ES2182852T3 (es) | Derivados de prolinamida. | |
DK0508699T3 (da) | 9-deoxo-8a-aza-8a-homoerythromycin-A-derivater modificeret ved 4"- og 8a-stillingerne | |
ATE398128T1 (de) | Neue purinderivate, deren herstelllung und deren verwendung als arzneimittel | |
TNSN05165A1 (fr) | Derives de pyrrolopyrimidine | |
BR9905981A (pt) | Compostos isocromano e processos para a sua produção. | |
SG11201804100UA (en) | Pharmaceutical composition comprising a potent inhibitor of urat1 | |
KR890008137A (ko) | 3-[4(1-치환된-4-피페라지닐)부틸]-4-티아졸리디노 이의 제조방법 및 약제로서의 이의 용도 | |
MXPA04002338A (es) | Derivados de carbazol y su uso como antagonistas receptores del npy5. | |
NO964121D0 (no) | Pyrimidin- eller triazin-karboksylsyrederivater for anvendelse som legemidler | |
DE60032016D1 (de) | Zyklische aminverbindungen als ccr5-rezeptor antagonisten | |
ATE402151T1 (de) | 2-(arylphenyl)amino-imidazolin-derivate | |
AR044014A1 (es) | Composiciones farmaceuticas para administracion intranasal de acido [2-(8,9-dioxo-2, 6-diazabiciclo [5.2.0) non-1 (7) -en-2-il)alquil]-fosfonico y derivados y metodos de utilizacion de las mismas | |
DK1340757T3 (da) | 1-methylcarbapenemderivater | |
BRPI0507802A (pt) | composto, composição, e, método para tratar inflamação ou um distúrbio metabólico | |
ATE402179T1 (de) | Indolderivate und deren verwendung in medikamenten | |
KR950032194A (ko) | 신규푸린유도체 및 그 약학적으로 허용되는 염 | |
NO982107L (no) | Fremstilling av et salt av klavulansyre | |
NO975903D0 (no) | N-benzylpiperazin-forbindelser, fremgangsmåte ved fremstilling derav, samt farmasöytiske blandinger | |
ATE17853T1 (de) | Bis-hydroxymethyl carbonat-derivate als antibakterielle mittel. | |
AU2003236180A1 (en) | Hydroxymorpholinone derivative and medicinal use thereof | |
BR9810031A (pt) | Derivados de ácido pirrolidina carboxìlico como antagonistas á endotelina | |
NO961657L (no) | Dibenz[b,eÅoksepinderivater, fremgangsmåte for fremstilling samt legemiddel inneholdende slike | |
ATE361307T1 (de) | Neue arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1437353 Country of ref document: EP |